Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2024-03-15 Director's Dealing
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Navamedic ASA - Mandatory notification of trade by primary insider
Director's Dealing Classification · 100% confidence The document details transactions involving 'person discharging managerial responsibilities' (Primary insider: CFO, Sales and Marketing Director) exercising share options and subscribing to new shares. This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing. Filing Definition 9: Director's Dealing (Code: DIRS) - Report of personal share transactions by company directors and executives (insider trades).
2024-03-15 English
Navamedic ASA - Mandatory notification of trade by primary insider
Share Issue/Capital Change Classification · 99% confidence The document is titled 'Navamedic ASA - Mandatory notification of trade by primary insider' and details the exercise of share options by key executives (CFO and Sales and Marketing Director) resulting in the subscription of new shares. This directly relates to personal share transactions by company directors and executives, which falls under the definition of Director's Dealing. Although it mentions a share capital increase (CAP), the primary focus and mandatory notification requirement concern the insider trading aspect. Therefore, the most appropriate code is DIRS.
2024-03-15 English
Navamedic ASA: Resolution to increase the share capital in connection with exercise of employee options
Share Issue/Capital Change Classification · 98% confidence The document explicitly announces a 'Resolution to increase the share capital in connection with exercise of employee options.' It details the number of new shares issued (80,000), the nominal value, and the resulting total share capital. This action directly relates to changes in the company's capital structure due to employee compensation/share issuance, which aligns best with the 'Share Issue/Capital Change' definition (SHA). It is not a general financing update (CAP) but a specific execution of a share issuance plan.
2024-03-15 English
Navamedic welcomes new shareholders
Major Shareholding Notification Classification · 99% confidence The document is a short press release dated March 13, 2024, announcing that Ingerø Reiten Investment Company (IRIC) sold its entire 17.1% stake in Navamedic, and the company welcomes new shareholders. It discusses management's continued ownership (16.7%) and highlights recent company performance (tripled turnover, profitability). This type of announcement, detailing changes in significant share ownership or major shareholder activity, aligns best with the 'Major Shareholding Notification' category (MRQ), as it directly concerns a change in a significant ownership block (17.1% sale). While it is a general announcement, MRQ is more specific than the general 'RNS' fallback.
2024-03-13 English
Navamedic ASA – Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is titled 'Navamedic ASA – Notification of Major Holdings'. It explicitly details a transaction where an entity (Hausta Investor AS) acquired shares, resulting in their holding crossing a threshold (5.26%). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels.
2024-03-13 English
Navamedic ASA: Notification of major shareholding and mandatory notification of trade
Director's Dealing Classification · 100% confidence The document text consists of structured data detailing a transaction involving shares of Navamedic ASA. Specifically, it reports the 'Sale' of shares by a 'person closely associated' with the chairman and board member, including the date (2024-03-12), price (NOK 32 per share), and volume (2,965,618 shares). This format and content—reporting personal share transactions by directors or closely associated persons—perfectly matches the definition of a Director's Dealing report.
2024-03-12 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.